Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Irini Sereti, MD
National Institute for Allergy and Infectious Diseases, National Institutes of Health
Study Chair - Michael M. Lederman, MD
Case Western Reserve University, University Hospitals of Cleveland
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Univ. of California Davis Med. Ctr., Actu
Sacramento, California, United States
- Univ. of Miami Aids Crs
Miami, Florida, United States
- Rush Univ. Med. Ctr. Actg Crs
Chicago, Illinois, United States
- Case Crs
Cleveland, Ohio, United States
- Metrohealth Crs
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2005
- Primary completion
- —
- Completion
- 30 Apr 2007
- Last update posted
- 1 Nov 2021
- Registered enrollment
- 25
- Registry id
- NCT00099671
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.